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LETTERS TO THE EDITOR/ERRATA11581 from each side, and crossed in the midline, creating a sphincter over the tube. The incorporation
of this continence procedure enables the surgeon to do minimal mobilization of the anterior wall
of the bladder, almost like performing an open incontinent cystostomy. One of the most appealing
indications for using this approach is the prune-belly syndrome.1
Respectfully,
Antonio Macedo, Jr.
Department of Urology
Federal University of São Paulo
São Paulo, Brazil1. Macedo A Jr, Rosito T, Pires JA et al: A new extra-abdominal channel
alternative to the Mitrofanoff principle: experimental and preliminary
clinical experience. Int Braz J Urol 2009; 35: 205.
2. Liguori R, Rosito T, Pires JA et al: A new extra-abdominal channelIn an elegant fashion they show beneficial effects ofdominal cutaneous flaps: preliminary clinical experience. J Pediatr
Urol, suppl, 2010; 6: S44.
3. Yachia D: A new continent vesicostomy technique: preliminary report.alternative to the Mitrofanoff principle based on two lower ab- J Urol 1997; 157: 1633
Reply by Authors: We would like to thank Macedo for his interesting comment. We totally agree
that the concept of a pedicled skin flap to create a conduit is not new, since skin flaps have been
used in hypospadias surgery. That is why Daoud began using this type of conduit for continent
cystostomy in 1999. The technique and our preliminary results were reported at the 2004
European Society for Paediatric Urology meeting in Regensburg.1
We are interested in the report of Rackley. This notion is, indeed, close to our technique, except
we think that the proximal cutaneous incision could be avoided. In his comment Macedo presents
the concept of 2 flaps, elevated from each side of the lower abdomen. One of our concerns regards
the hairiness of the tube, which is particularly difficult to anticipate in young children. Macedo
and Rackley do the cystostomy in the middle line, which can be hairy during adulthood. At the
beginning of our experience we elected to use a paraumbilical pedicle to avoid the middle line.
As reported, we currently tend to use a lateral flap, which seems more convenient for that
particular indication (figure 7 in article). The incision is then transverse and more discrete.
We have no experience with the technique of Yachia regarding the continence procedure, and
we agree that this point of the technique can be difficult, especially in patients who have
undergone multiple surgeries (eg previous bladder enlargement, cervical procedures). That is
why we sometimes do the extramucosal incision laterally to avoid the post-scarring fibrosis. Our
cutaneous flap is not systematized and we can then choose the most convenient place for the
abdominal opening, according to previously stated principles and patient clinical status. As
described by Cervellione in the editorial comment that accompanied our article, in our latest
patients we pass the channel between the rectus sheath and the rectus muscle. We cannot yet
assess the results, but maybe this easy to do gesture will shorten the extramucosal incision and
limit the need for bladder exposure, at least in difficult cases. Dysfunctional bladder management
still remains a challenge, and any technical gesture, new or already applied, must be thoroughly
understood and discussed while keeping in mind the long-term outcomes.
1. Poli-Merol ML, Belouadah M, Challemet C et al: Use of a cutaneous flap for continent vesicostomy: an interesting alternative. BJU Int, suppl, 2004;
93: 31.
Re: Transplantation of Nonhematopoietic Adult Bone Marrow
Stem/Progenitor Cells Isolated by p75 Nerve Growth Factor
Receptor Into the Penis Rescues Erectile Function in a Rat Model
of Cavernous Nerve Injury
M. Kendirci, L. Trost, B. Bakondi, M. J. Whitney, W. J. G. Hellstrom and J. L. Spees
J Urol 2010; 184: 1560–1566.
To the Editor: Wewish to congratulate the authors on a beautifully conducted and written study.
transplantation of autologous rat multipotent
LETTERS TO THE EDITOR/ERRATA 1159stromal cells (rMSCs) and p75 positive selected rMSC on erectile function in a standardized rat
model of bilateral cavernous nerve injury (CNI). Interestingly they propose paracrine signaling
as the capital mechanism of action of MSC therapy for cavernous nerve injury based on a paucity
of stem cell engraftment and a mesenchymal morphology of the rare stem cells remaining in the
erectile tissue. Furthermore, they demonstrated a higher secretory capacity of rMSCs and p75
rMSCs compared to fibroblast controls.
A recent series of publications marks a shift in the paradigm that MSC effects are
established by incorporation in the host tissue, toward a way of thinking that MSC might
have important paracrine effects on the host tissue. Although in vitro (trans)differentiation
is easily induced in MSCs, various studies outside the field of sexual medicine, have shown
unsatisfactory results regarding in vivo engraftment of MSC.1 Furthermore, two important
observations support the hypothesis that MSC have paracrine effects on the host tissue. The
beneficial effects of MSCs have been observed within 3 days following transplantation, a time
frame that is too small to allow for engraftment and differentiation. Also, and perhaps most
striking, the beneficial effects of MSCs have been replicated using cell-free lysate and
conditioned MSC culture medium.1,2 MSCs hold great secretory potential, which is confirmed
in this study.
The authors importantly recognize that MSCs likely do not exert their beneficial effects by
engraftment in the CNI rat model. Our group previously showed that mesenchymal stem cells
cultured from adipose tissue (ADSC) were able to induce recovery of erectile function
following CNI in rats.3 This recovery was accompanied by a recovery of neuronal nitric oxide
synthase expression in the penile nerves, analogous with the proposal by Kendirci et al that
MSC might work via potentiation of nerve regeneration. Interestingly these results were
almost entirely replicated by injection of cell-free lysate derived from ADSC, thereby expos-
ing the host to soluble molecules contained in ADSC while excluding the possibility of
engraftment. Fall et al injected bone marrow mononuclear cells following CNI and showed
retained PKH-26 cell label in the cavernous tissue surrounding the sinusoids but did not
demonstrate individual cell morphology.4 Furthermore, no differentiation was observed.
Fandel et al showed a time dependent decrease in penile ADSC numbers in CNI rats with
almost none remaining at 28 days following intracavernous injection.5 Furthermore, ADSC
conditioned medium has been shown to promote neurite outgrowth from cultured rat major
pelvic ganglion.6 The results of these studies strongly argue for paracrine mechanisms of
actions, while strong evidence for penile stem cell engraftment following CNI is generally
lacking.
Additional research is indicated to characterize these findings further. Specifically following
cancer treatment it is important to determine whether paracrine signaling molecules secreted by
MSC could have tumorigenic effects.
Respectfully,
Maarten Albersen and Tom F. Lue
Department of Urology
University Hospitals Leuven
Leuven, Belgium
and Department of Urology
School of Medicine
University of California, San Francisco
San Francisco, California
e-mail: maarten.albersen@uzleuven.be
Reply by Authors: We appreciate the kind words of Albersen and Lue regarding our recent
article. Their letter raises several important points regarding the mechanism(s) responsible for
the benefits conferred by administering bone marrowMSCs (BMSCs), bone marrow mononuclear
cells (BMCs), or ADSCs after tissue injury.2,3,7 Unlike the case with robust marrow engraftment
of uncultured hematopoietic stem/progenitor cells after transplantation into ablated hosts, in-
travenous or intra-arterial infusion or direct injection of cultured adult nonhematopoietic stem/
progenitor cells into injured tissues frequently results in low long-term cell engraftment. Nota-
bly, despite low cell engraftment, adult stem/progenitor cell administration is often found to
LETTERS TO THE EDITOR/ERRATA1160correlate with preservation or partial repair of tissue and, in many cases, significant functional
improvement.1 These observations lend support to the “paracrine hypothesis”, namely that
rescue and repair of injured tissue after cell transplantation occurs primarily through the release
of secreted growth factors, cytokines, and hormones by transplanted cells rather than through
differentiation and direct replacement of injured cells.
Albersen et al recently began to address the paracrine hypothesis for ADSC treatment after
cavernous nerve injury (CNI) by comparing the effects of administering ADSCs or ADSC lysates.
Interestingly, they found little difference in the protection provided against erectile dysfunction
by ADSCs or ADSC lysates.3 Although both treatments were effective, they may provide benefit
through different mechanisms. Infusion of cell lysates may not reflect the composition of factors
secreted by transplanted cells during short-term engraftment. Further study is now needed to
determine whether administered adult stem/progenitor cells actually lyse in large numbers and
release their cellular contents in an unregulated manner, or act transiently to secrete specific
molecules in response to cues from injured tissues. Recent studies support the latter mechanism,
although lysis of some cells and regulated secretion from others could conceivably occur simul-
taneously.4,5,6
We found that human BMSCs isolated from marrow aspirates by sorting against CD133
engrafted for 48 hours following direct injection into cortical peri-infarct areas after stroke.
Human specific real-time polymerase chain reaction assays demonstrated that the CD133 BMSCs
injected into peri-infarct areas increased their SDF-1 mRNA levels about 80-fold compared with
CD133 BMSCs injected into sham operated cortical tissue.8 Lee et al reported that TSG-6, an
anti-inflammatory protein, was produced and secreted by human BMSCs at significantly higher
levels after the cells lodged in the lung following intravenous infusion.9 These results indicate
that the expression and secretion of some reparative factors may be altered dramatically once
cultured cells encounter different environments in vivo. Although typically thought to be bene-
ficial, the ability of transplanted adult stem/progenitor cells to respond to new environments in
vivo should be carefully considered, since such responses could vary for individuals with different
case histories. Importantly this issue could contribute to variability in treatment outcomes.
An additional point raised by Albersen and Lue concerns the physiological aspects of benefit
acquired through adult stem/progenitor cell transplantation after CNI. In addition to the bio-
chemistry behind the effects, what cells are responding and how does their response lead to the
prevention of erectile dysfunction after CNI? Direct neuroprotection is a possible mechanism, and
this concept is in line with the observed recovery of neuronal nitric oxide synthase expression in
penile neurons detected by Albersen et al after ADSC transplantation.3 The marked secretion by
p75 MSCs of bFGF, a growth factor well known to provide neuroprotection, also supports the idea
of direct neuroprotection in our CNI model.10 However, indirect physiological mechanisms are
also possible. For example many of the growth factors secreted by non-hematopoietic progenitor
cells are vasoprotective and/or angiogenic. Improved neuronal survival or function could occur
indirectly because of improved vascular perfusion. Accordingly another avenue of future studies
should focus on identifying physiological mechanisms in addition to biochemical mechanisms of
treatment effects after cell transplantation.
Because cell engraftment may not actually be necessary to achieve the paracrine or secreted
effects of adult stem/progenitor cells, it may be possible to infuse instead a cocktail of secreted
molecules prepared from cultured cells or even defined combinations of proteins/peptides. In
other studies with human CD133 BMSCs we found that intra-arterial infusion of serum-free
concentrated conditioned medium (CD133 BMSC CdM) provided significantly greater preserva-
tion of cortical tissue after stroke compared with infusion of cells.11 Similarly CdM generated
from human p75 selected MSCs may provide an effective treatment to protect against nerve
damage after radical prostatectomy. Ultimately biochemical analysis of p75 MSC CdM or CdMs
from other cells may lead to the identification of several active factors and a recipe for a powerful
combination therapeutic to provide vasoprotection and/or neuroprotection after injury.1. Crisostomo PR, Markel TA, Wang Y et al: Surgically relevant aspects
of stem cell paracrine effects. Surgery 2008; 143: 577.
2. Yeghiazarians Y, Zhang Y, Prasad M et al: Injection of bone marrow
cell extract into infarcted hearts results in functional improvement
comparable to intact cell therapy. Mol Ther 2009; 17: 1250.3. Albersen M, Fandel TM, Lin G et al: Injections of adipose tissue-
derived stem cells and stem cell lysate improve recovery of erectile
function in a rat model of cavernous nerve injury. J Sex Med 2010;
Epub ahead of print.
LETTERS TO THE EDITOR/ERRATA 11614. Fall PA, Izikki M, Tu L et al: Apoptosis and effects of intracavernous
bone marrow cell injection in a rat model of postprostatectomy
erectile dysfunction. Eur Urol 2009; 56: 716.
5. Fandel TM, Albersen M, Lin G et al: Tracking of injected adipose
tissue-derived stem cells after cavernous nerve injury in rats: injury-
induced homing to the major pelvic ganglion. Unpublished data.
6. Bella AJ, Garcia M, Lin G et al: Adult adipose tissue derived stem
cells enhance neurite outgrowth from the major pelvic ganglion of
the rat. CUAJ 2007; 1: 200, abstract 2.01.
7. Iso Y, Spees JL, Serrano C et al: Multipotent human stromal cells
improve cardiac function after myocardial infarction in mice without
long-term engraftment. Biochem Biophys Res Commun 2007; 354:
700.8. Gnecchi M, Zhang Z, Ni A et al: Paracrine mechanisms in adult stem
cell signaling and therapy. Circ Res 2008; 103: 1204.
9. Bakondi B, Shimada IS, Peterson BM et al: SDF-1 secreted by human
CD133-derived MSCs promotes neural progenitor cell survival
through CXCR7. Stem Cells Dev 2010; Epub ahead of print.
10. Lee RH, Pulin AA, Seo MJ et al: Intravenous hMSCs improve
myocardial infarction in mice because cells embolized in lung are
activated to secrete the anti-inflammatory protein TSG-6. Cell Stem
Cell 2009; 5: 54.
11. Bakondi B, Shimada IS, Perry A et al: CD133 identifies a human bone
marrow stem/progenitor cell sub-population with a repertoire of
secreted factors that protect against stroke. Mol Ther 2009; 17: 1938.ERRATA
THIS MONTH IN PEDIATRIC UROLOGY
Volume 185, Number 1, Page 3, Column 1: Four sentences before the last sentence in the commentary
on “Late Phase Renal Scintigraphy and Ultrasound Screening of Urinary Tract Infection” should state:
“Using the OR rule the sensitivity for detecting dilating VUR was 97% and the diagnostic odds ratio was
25.3. In this scenario of 533 patients only 336 (63%) would undergo VCUG, resulting in failure to detect
9 (6.2%) with dilating VUR. Using the “AND rule” the sensitivity and NPV decreased to 69% and 87%,
respectively, with a diagnostic odds ratio of 16.4, and only 177 (33.2%) patients would undergo VCUG,
resulting in failure to detect 39 (27%) with dilating VUR.”
SHOCK WAVE LITHOTRIPSY AND HYPERTENSION RISK
Volume 185, Number 1, Page 164: This study was also supported by the Rochester Epidemiology
Project Grant number R01 AG034656 from the National Institute on Aging.
